Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03583775 · ClinicalTrials.gov registry record

3D Cine Cardiovascular Magnetic Resonance

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
51
Enrollment target

NCT03583775: Completed study, sponsored by Boston Children's Hospital.

NCT03583775 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03583775 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

Conventional CMR is based on breath-hold 2D cine image acquisitions which are sequentially acquired in different imaging planes. The necessity of precisely planning and then acquiring multiple 2D imaging planes during breath-hold is relatively inefficient and leads to CMR exam times of ≤60 minutes. However, some patients are too ill or young to hold their breath. Furthermore, 2D images sometimes fail to provide a complete picture of complex 3D anatomy of patients with complex morphology. To address these limitations, we have recently developed a 3D cine (3 spatial dimensions plus time) CMR technique. Rather than acquiring 2D cine images in multiple orientations during breath-hold, this approach allows one to acquire a free-breathing 3D block of data for each phase of cardiac cycle that can be reformatted offline into the desired views without adding to the exam time. This added efficiency should lead to a reduction in CMR exam time, increasing patient comfort, and making CMR exam easy and available for all. In addition, the 3D nature of the data may yield more complete information about the anatomy and physiology. In this proposal, we will examine the agreement between the 2D cine and 3D cine CMR techniques with regard to left and right ventricular volumes and systemic and pulmonary blood flow circulation. The internal consistency of the measurements between the 2 techniques will be also investigated. This study will focus on children because they may benefit the most from the short, improved efficiency, and free-breathing CMR exams.

Interventions

  • OTHER Cardiovascular Magnetic Resonance Imaging

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2019-11-01
Est. Completion 2021-10-04
Boston Children's Hospital

462 total trials

What the finished NCT03583775 record still lists

NCT03583775 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Cardiovascular Magnetic Resonance Imaging is the first listed.

NCT03583775 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03583775 about?

NCT03583775 is a clinical study titled "3D Cine Cardiovascular Magnetic Resonance". Conventional CMR is based on breath-hold 2D cine image acquisitions which are sequentially acquired in different imaging planes. The necessity of precisely planning and then acquiring multiple 2D imaging planes during breath-hold is relatively inefficient and leads to CMR exam times of ≤60 minutes. ...

What is the current status of trial NCT03583775?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2019-11-01. Estimated completion is 2021-10-04.

What interventions are being tested in trial NCT03583775?

The interventions under investigation include: Cardiovascular Magnetic Resonance Imaging (OTHER).

Who is sponsoring clinical trial NCT03583775?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03583775, the US trial registry maintained by the National Library of Medicine. NCT03583775 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.